← Eichor
Study identifier: NCT05546931 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Mobile Health Program for Rural Hypertension

Condition: Hypertension,Essential · Adherence, Medication · Quality of Life  ·  Sponsor: University of Pittsburgh

PhaseNA
Planned participants334
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Hypertension (HTN) is the leading modifiable cause of cardiovascular disease. Rural individuals experience challenges of the rural health divide: geographic distance from providers, social isolation, limited social resources, and high rates of low health literacy. This study evaluates a home-based blood pressure monitoring (HBPM) program that provides longitudinal health education, empathic guidance, monitoring, and adaptable patient-centered coaching to rural individuals. Participants in this study will be randomized to receive (1) HBPM with the intervention; or (2) the control, consisting of HBPM and a smartphone with a general health application (WebMD).

This description comes directly from the study's public registry record.

Talk to the study team

Jared W Magnani, MD  ·  4123830611  ·  magnanij@pitt.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Pittsburgh Medical CenterPittsburgh, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05546931